Pharvaris N.V. (PHVS) Social Stream
PHARVARIS NV (PHVS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PHARVARIS NV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-12 | 4 | $51 | $21 | $42.5 | $26.25 | 61.9% |
| 2022-01-18 | 4 | $50 | $21 | $42.25 | $26.25 | 60.95% |
| 2022-02-07 | 3 | $50 | $21 | $40 | $26.25 | 52.38% |
| 2022-04-04 | 4 | $50 | $21 | $40 | $26.25 | 52.38% |
| 2022-04-26 | 4 | $48 | $21 | $38.75 | $26.25 | 47.62% |
| 2022-05-16 | 4 | $48 | $21 | $38.5 | $26.25 | 46.67% |
| 2022-05-25 | 5 | $48 | $21 | $37.6 | $26.25 | 43.24% |
| 2022-05-27 | 5 | $48 | $20 | $37.4 | $26.25 | 42.48% |
| 2022-07-06 | 5 | $48 | $20 | $37.4 | $26.25 | 42.48% |
| 2022-08-13 | 5 | $48 | $26 | $38.6 | $26.25 | 47.05% |
| 2022-08-23 | 5 | $34 | $10 | $20.8 | $26.25 | -20.76% |
| 2022-11-02 | 5 | $22 | $10 | $16.6 | $26.25 | -36.76% |
| 2022-12-08 | 5 | $22 | $5 | $15 | $26.25 | -42.86% |
| 2022-12-09 | 5 | $24 | $8 | $16.8 | $26.25 | -36% |
| 2023-01-27 | 5 | $24 | $8 | $17 | $26.25 | -35.24% |
| 2023-04-05 | 5 | $24 | $8 | $16.6 | $26.25 | -36.76% |
| 2023-06-06 | 5 | $24 | $8 | $16 | $26.25 | -39.05% |
| 2023-06-27 | 5 | $26 | $8 | $16.8 | $26.25 | -36% |
| 2023-08-14 | 5 | $26 | $8 | $17.6 | $26.25 | -32.95% |
| 2023-08-15 | 5 | $34 | $8 | $22.4 | $26.25 | -14.67% |
| 2023-08-17 | 6 | $34 | $8 | $22.4 | $26.25 | -14.67% |
| 2023-10-18 | 6 | $34 | $8 | $23.166 | $26.25 | -11.75% |
| 2023-11-13 | 6 | $34 | $8 | $22.666 | $26.25 | -13.65% |
| 2023-11-17 | 6 | $32 | $8 | $22.333 | $26.25 | -14.92% |
| 2023-12-07 | 6 | $36 | $11 | $25 | $26.25 | -4.76% |
| 2023-12-19 | 6 | $36 | $11 | $28.5 | $26.25 | 8.57% |
The Trend in the Analyst Price Target
PHVS's average price target has moved down $12.03 over the prior 34 months.
PHVS reports an average of 41.01% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 5 | 24 | 8 | 17.0 | 10.11 | 68.15% |
| 2023-02-03 | 5 | 24 | 8 | 16.6 | 9.18 | 80.83% |
| 2023-06-27 | 5 | 26 | 8 | 16.4 | 16.00 | 2.5% |
| 2023-08-15 | 5 | 34 | 8 | 22.4 | 20.00 | 12% |
| 2023-12-07 | 6 | 36 | 11 | 25.0 | 25.42 | -1.65% |
PHVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 5 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
PHVS's average broker recommendation rating improved by 0.5 over the prior 14 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how PHARVARIS NV fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2170.77% of that group.
- PHARVARIS NV's upside potential (average analyst target price relative to current price) is higher than 826.62% of all US stocks.
- In the context of Healthcare stocks, PHARVARIS NV's number of analysts covering the stock is higher than 674.45% of them.
- PHARVARIS NV's average analyst price target is greater than 1741.44% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ADAG, LGVN, and CNTB are the three stocks most similar to PHARVARIS NV regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding PHVS using the data that counts. Try POWR Ratings for free.